Astragaloside IV prevents MPP+-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production

Molecular and Cellular Biochemistry

Volumn 364, Issue 1-2, 2012, Pages 209-216

  Zhang, Zhi Guo ^a   Wu, Lin ^a   Wang, Ju Lei ^a   Yang, Jian Dong ^b   Zhang, Jing ^a   Zhang, Jian ^a   Li, Li Hong ^a   Xia, Yi ^a   Yao, Li Bo ^a   Qin, Huai Zhou ^a   Gao, Guo Dong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Astragaloside IV; MPP+; Parkinson's disease; Reactive oxygen species

Indexed keywords

1 METHYL 4 PHENYLPYRIDNIUM; ASTRAGALOSIDE IV; PROTEIN BAX; PROTEIN BCL 2; PYRIDINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; HUMAN; HUMAN CELL; NEUROPROTECTION; NEUROTOXICITY;

1-METHYL-4-PHENYLPYRIDINIUM; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION; HUMANS; NEUROBLASTOMA; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SAPONINS; TRITERPENES;

EID: 84863985925     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1219-1     Document Type: Article

References (48)

1. De Lau LM, Breteler MM (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5:525-535 (Pubitemid 44262284)
2. Mattson MP (2000) Apoptosis in neurodegenerative disorders. Natl Rev Mol Cell Biol 1:120-129
3. Brown JM, Yamamoto BK (2003) Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol Ther 99:45-53 (Pubitemid 36694749)
4. Seniuk NA, Tatton WG, Greenwood CE (1990) Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP. Brain Res 527:7-20 (Pubitemid 20290579)
5. Hantraye P, Varastet M, Peschanski M, Riche D, Cesaro P, Willer JC, Maziere M (1993) Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons. Neuroscience 53:169-178 (Pubitemid 23083318)
6. Singer TP, Ramsay RR (1990) Mechanism of the neurotoxicity of MPTP. An update. FEBS Lett 274:1-8 (Pubitemid 20378107)
7. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADHlinked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine. Life Sci 36:2503-2508 (Pubitemid 15072756)
8. Przedborski S, Jackson-Lewis V (1998) Mechanisms of MPTP toxicity. Mov Disord 13(Suppl 1):35-38
9. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909 (Pubitemid 37130207)
10. Seaton TA, Cooper JM, Schapira AH (1997) Free radical scavengers protect dopaminergic cell lines from apoptosis induced by complex I inhibitors. Brain Res 777:110-118 (Pubitemid 28015738)
11. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 65:135-172 (Pubitemid 32524182)
12. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132 (Pubitemid 27097312)
13. Crompton M (2000) Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr Opin Cell Biol 12:414-419 (Pubitemid 30453590)
14. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312-1316 (Pubitemid 28406817)
15. Di Monte D, Sandy MS, Ekstrom G, Smith MT (1986) Comparative studies on the mechanisms of paraquat and 1-methyl-4-phenylpyridine (MPP?) cytotoxicity. Biochem Biophys Res Commun 137:303-309 (Pubitemid 16056066)
16. Cassarino DS, Parks JK, Parker WJ, Bennett JJ (1999) The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta 1453:49-62 (Pubitemid 29065457)
17. Luo Y, Qin Z, Hong Z, Zhang X, Ding D, Fu JH, Zhang WD, Chen J (2004) Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neurosci Lett 363:218-223 (Pubitemid 38746516)
18. Zhang WJ, Hufnagl P, Binder BR, Wojta J (2003) Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF-kappaB activation and adhesion molecule expression. Thromb Haemost 90:904-914 (Pubitemid 37427861)
19. Zhang WD, Zhang C, Liu RH, Li HL, Zhang JT, Mao C, Moran S, Chen CL (2006) Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs. Life Sci 79:808-815 (Pubitemid 43975129)
20. Yang J, Li Y, Wu L, Zhang Z, Han T, Guo H, Jiang N, Tao K, Ti Z, Liu X, Yao L, Dou K (2010) NDRG2 in rat liver regeneration: role in proliferation and apoptosis. Wound Repair Regen 18:524-531
21. DoY Lee, Lee KS, Lee HJ, Noh YH, DoH Kim, Lee JY, Cho SH, Yoon OJ, Lee WB, Kim KY, Chung YH, Kim SS (2008) Kynurenic acid attenuates MPP?-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway. Eur J Cell Biol 87:389-397
22. LeBel CP, Ali SF, McKee M, Bondy SC (1990) Organometalinduced increases in oxygen reactive species: the potential of 20, 70-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol Appl Pharmacol 104:17-24 (Pubitemid 20186895)
23. O'Malley KL, Liu J, Lotharius J, Holtz W (2003) Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons. Neurobiol Dis 14:43-51 (Pubitemid 37103178)
24. Kaul S, Kanthasamy A, Kitazawa M, Anantharam V, Kanthasamy AG (2003) Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP?)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci 18:1387-1401 (Pubitemid 37215094)
25. Adams JJ, Klaidman LK, Leung AC (1993) MPP+ and MPDP+ induced oxygen radical formation with mitochondrial enzymes. Free Radic Biol Med 15:181-186 (Pubitemid 23218820)
26. Cheng CY, Yao CH, Liu BS, Liu CJ, Chen GW, Chen YS (2006) The role of astragaloside in regeneration of the peripheral nerve system. J Biomed Mater Res A 76:463-469
27. Chan WS, Durairajan SS, Lu JH, Wang Y, Xie LX, Kum WF, Koo I, Yung KK, Li M (2009) Neuroprotective effects of astragaloside IV in 6-hydroxydopamine- treated primary nigral cell culture. Neurochem Int 55:414-422
28. Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ (1983) A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550 (Pubitemid 13077876)
29. Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647-656 (Pubitemid 37328916)
30. Tanaka K, Asanuma M, Ogawa N (2004) Molecular basis of antiapoptotic effect of immunophilin ligands on hydrogen peroxideinduced apoptosis in human glioma cells. Neurochem Res 29:1529-1536 (Pubitemid 38860234)
31. Levy OA, Malagelada C, Greene LA (2009) Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 14:478-500
32. Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S (2001) Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease. Proc Natl Acad Sci USA 98:2837-2842 (Pubitemid 32209570)
33. Offen D, Beart PM, Cheung NS, Pascoe CJ, Hochman A, Gorodin S, Melamed E, Bernard R, Bernard O (1998) Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity. Proc Natl Acad Sci USA 95:5789-5794 (Pubitemid 28224175)
34. Yang L, Matthews RT, Schulz JB, Klockgether T, Liao AW, Martinou JC, Penney JJ, Hyman BT, Beal MF (1998) 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J Neurosci 18:8145-8152 (Pubitemid 28464993)
35. Findley HW, Gu L, Yeager AM, Zhou M (1997) Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 89:2986-2993 (Pubitemid 27172586)
36. Li PF, Dietz R, von Harsdorf R (1999) p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 18:6027-6036 (Pubitemid 29515679)
37. Mandir AS, Przedborski S, Jackson-Lewis V, Wang ZQ, Simbulan-Rosenthal CM, Smulson ME, Hoffman BE, Guastella DB, Dawson VL, Dawson TM (1999) Poly (ADP-ribose) polymerase activation mediates 1-methyl-4 (MPTP)-induced parkinsonism. Proc Natl Acad Sci USA 96:5774-5779 (Pubitemid 29234694)
38. Gao M, Zhang WC, Liu QS, Hu JJ, Liu GT, Du GH (2008) Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2 ratio. Eur J Pharmacol 591:73-79
39. Saporito MS, Thomas BA, Scott RW (2000) MPTP activates c-Jun. NH (2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J Neurochem 75:1200-1208 (Pubitemid 30660510)
40. Xia XG, Harding T, Weller M, Bieneman A, Uney JB, Schulz JB (2001) Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 98:10433-10438 (Pubitemid 32803037)
41. Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prigent A, Turmel H, Srinivasan A, Ruberg M, Evan GI, Agid Y, Hirsch EC (2000) Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci USA 97:2875-2880 (Pubitemid 30159265)
42. Bronstein JM, Chou AP (2006) Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology 67:182 author reply 182 (Pubitemid 44305497)
43. Ko JK, Lam FY, Cheung AP (2005) Amelioration of experimental colitis by astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 11:5787-5794 (Pubitemid 41662827)
44. Higuchi M, Honda T, Proske RJ, Yeh ET (1998) Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 17:2753-2760 (Pubitemid 28554234)
45. Gu Y, Wang G, Fawcett JP (2004) Determination of astragaloside IV in rat plasma by liquid chromatography electrospray ionization mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 801:285-288 (Pubitemid 38130078)
46. Zhang W, Zhang C, Liu R, Li H, Zhang J, Mao C, Chen C (2005) Quantitative determination of astragaloside IV, a natural product with cardioprotective activity, in plasma, urine and other biological samples by HPLC coupled with tandem mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 822:170-177 (Pubitemid 40994049)
47. Huang C, Wang G, Li H, Xie H, Sun J, Lv H, Lv T (2006) Sensitive and selective liquid chromatography-electrospray ionisationmass spectrometry analysis of astragaloside-IV in rat plasma. J Pharm Biomed Anal 40:788-793 (Pubitemid 43227404)
48. Wen XD, Qi LW, Li P, Bao KD, Yan XW, Yi L, Li CY (2008) Simultaneous determination of calycosin-7-O-beta-D-glucoside, ononin, astragaloside IV, astragaloside I and ferulic acid in rat plasma after oral administration of Danggui Buxue Tang extract for their pharmacokinetic studies by liquid chromatography-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 865:99-105